- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Biomimetic Nanoparticles for the Treatment of Hematologic Malignancies ; year:2021
Advanced nanoBiomed research ; (2021)
- Urheber
-
Powsner, Emily H.
Harris, Jenna C.
Day, Emily S.
- DOI
-
10.1002/anbr.202000047
- URN
-
urn:nbn:de:101:1-2021020908145411690044
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Powsner, Emily H.
- Harris, Jenna C.
- Day, Emily S.
Ähnliche Objekte (12)
Hematologic malignancies
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Identification and characterization of T Lymphocytes for the treatment of hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future
Hematologic malignancies
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Identification and characterization of T Lymphocytes for the treatment of hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future
Hematologic malignancies
Bispecific Antibodies in the Treatment of Hematologic Malignancies
Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Identification and characterization of T Lymphocytes for the treatment of hematologic malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
CAR-T cell combination therapies in hematologic malignancies